Kardigan, Inc. (KARD)
NASDAQ: KARD · Real-Time Price · USD
21.14
+1.54 (7.86%)
Sep 2, 2026, 12:11 PM EDT - Market open
Kardigan Employees
Kardigan had 241 employees as of March 31, 2026. The number of employees did not change since the number was last reported on December 31, 2025.
Employees
241
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,198,274
Market Cap
1.98B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2026 | 241 | 0 | - |
| Dec 31, 2025 | 241 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Recursion Pharmaceuticals | 600 |
| Immunocore Holdings | 524 |
| Maravai LifeSciences Holdings | 415 |
| Intellia Therapeutics | 377 |
| Vir Biotechnology | 367 |
| Lakefront Biotherapeutics NV | 196 |
| Septerna | 123 |
| Inhibrx Biosciences | 110 |
KARD News
- 8 days ago - Kardigan price target lowered to $46 from $51 at JPMorgan - TheFly
- 22 days ago - Kardigan reports Q2 EPS ($4.61) vs ($4.64) last year - TheFly
- 22 days ago - Kardigan Reports Second Quarter 2026 Financial Results and Recent Business Updates - Business Wire
- 22 days ago - Kardigan Earnings release: Q2 2026 - Filings
- 22 days ago - Kardigan Quarterly report: Q2 2026 - Filings
- 7 weeks ago - Kardigan initiated with an Outperform at Leerink - TheFly
- 7 weeks ago - Kardigan initiated with a Buy at TD Cowen - TheFly
- 7 weeks ago - Kardigan initiated with an Overweight at JPMorgan - TheFly